AF
CC icon

Ally Financial’s Chemours CC Stock Holding History

Ally Financial’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-4,000
Closed -$64K – 106
2016
Q3 		$64K Hold
4,000
– – 0.01% 100
2016
Q2 		$33K Hold
4,000
– – 0.01% 109
2016
Q1 		$28K Hold
4,000
– – ﹤0.01% 128
2015
Q4 		$21K Hold
4,000
– – ﹤0.01% 122
2015
Q3 		$26K Buy
+4,000
New +$41.9K ﹤0.01% 138

Other funds holding CC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

Ally Financial's CC Position: Q4 2016 in Review

Ally Financial sold out of Chemours (CC) in Q4 2016, closing a stake of 4,000 shares — an estimated $64K sold.

Ally Financial first reported a position in CC in Q3 2015 and held it in 5 quarters. The position peaked at $64K in Q3 2016. 417 funds tracked by Wall St. Rank hold CC as of Q4 2016.

  • Ally Financial reported no remaining Chemours position as of Q4 2016 after selling out during the quarter.
  • Ally Financial sold 4,000 Chemours shares in Q4 2016, an estimated $64K.
  • Ally Financial first reported a position in Chemours in Q3 2015 and held it in 5 quarters.
  • Ally Financial's Chemours position peaked at $64K in Q3 2016.
  • 417 funds tracked by Wall St. Rank held Chemours as of Q4 2016.

Based on Ally Financial's 13F filing for Q4 2016, filed 13 Feb 2017.